Finzati - Logo
ORGO logo

Organogenesis Holdings Inc.

ORGO • Drug Manufacturers - Specialty & Generic
$1.71
▲ +0.07 (+4.27%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$220.03M
Growth
—
Cash Flow
3/5
Trend
Mostly stable
Evidence
Positive revenue growth · 5.1%Reasonable earnings multiple · 17.73Manageable debt level · 0.31Healthy liquidity · 3.62
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:32 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1.71
Change4.27%
Shares Out128.67M
Market Cap$220.03M
Enterprise Value$240.89M
52W Range1.73 - 7.08
Beta1.33
P/E-2.44
P/S0.48
P/B1.48
P/FCF5.67
EV/Sales0.53

Investment DNA

How strong this company looks for long-term investors

60
out of 100
Business Quality
Margins, moat, returns
52/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
45/100
Price Attractiveness
Cheap or expensive today
86/100
Why this score▼
Positive revenue growth · 5.1%Reasonable earnings multiple · 17.73Manageable debt level · 0.31Healthy liquidity · 3.62

Analyst view

Analyst sentiment and price target

ORGO
Analyst sentiment
Based on 6 analyst votes · 2026-09-05
83/100
Bullish
Bullish
4
Hold
2
Bearish
0
Price Target
2026-08-07
Low
$3.00
Mean
$3.00
Median
$3.00
High
$3.00

Company Overview

IPO: 1/5/2017
Industry: Drug Manufacturers - Specialty & Generic
P/B i: 1.48
Debt / Equity i: 0.31
Operating Margin: 9.92%
Net Margin: 6.58%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.31
Current Ratio: 3.62
Quick Ratio: 3.32
Status: Good

Insider Transactions

Recent executive and insider activity

Grow Brian
Transaction: 01/10/2025
SELL
Change
-958
Price
$1.24
Filing
04/24/2026
Type
SELL
Grow Brian
Transaction: 01/10/2025
BUY
Change
+958
Price
$1.24
Filing
04/24/2026
Type
BUY
Driscoll Michael Joseph
Transaction: 03/09/2026
BUY
Change
+10,000
Price
$2.67
Filing
03/11/2026
Type
BUY